-----BEGIN PGP SIGNED MESSAGE-----
Hash: SHA1
Paul Bromley wrote:
> Anyone have one? I am presently writing one for our practice as we
> seem to be doing an inordinate number of lipids with all the
> subsequent workload. The Darlington PCT Guidelines seem reasonable,
> although I do not think we will go above 40mgs with Simvastatin.
> We are then likely to switch the non-responders to Atorva. I notice
> that these guidelines suggest a switch from Simva 40 to Atorva 40.
> Do others think there is any merit in starting at 10mgs? From past
> experience I have found Atorva 10 to be very effective.
> Additionally what is the rationale for switching those with side
> effects to Pravastatin?
>
Rosuva is cheaper than Atorva now, isn't it?
And if you want a different molecule from Simva, Rosuva is prehaps
more different than Prava.
-----BEGIN PGP SIGNATURE-----
Version: GnuPG v1.4.6 (GNU/Linux)
Comment: Using GnuPG with Mozilla - http://enigmail.mozdev.org
iD8DBQFHQFS3RtcsVjUuankRArWuAKCUmaYMsGmOD8vYv+fBkviGKFnJ+QCfe0cm
9WRqPMbslkZLpOiBLaupKQU=
=gchb
-----END PGP SIGNATURE-----
|